Casandra A. Murphy


  • Gettysburg College
  • Widener University School of Law
  • Pennsylvania
  • New Jersey
  • USDC, Eastern District of Pennsylvania

Casandra A. Murphy’s practice at Kessler Topaz Meltzer & Check, L.L.P. is focused on the areas of antitrust and complex consumer litigation. Casandra is presently litigating a number of class action lawsuits against large pharmaceutical manufacturers in antitrust cases alleging improper reverse payments and generic suppression schemes.

Casandra also served as a special assistant attorney general to several states in litigation involving the sales and marketing practices of major pharmaceutical companies.  These cases led to important injunctive relief and significant monetary recovery for those states.

Examples of Casandra’s recent notable cases include In re Flonase Antitrust Litigation ($150 million settlement on behalf of direct purchasers); and In re Wellbutrin SR Antitrust Litigation ($21.5 million settlement on behalf of end-payors).

Representative Outcomes
  • Represented direct purchasers in an antitrust action challenging GlaxoSmithKline’s efforts to unlawfully extend its monopoly on Flonase, the company’s blockbuster allergy medication.

    The lawsuit alleged that GlaxoSmithKline violated federal antitrust laws by filing a series of sham citizen petitions with the Food and Drug Administration. After several years of litigation, including depositions, expert reports and rebuttals, two rounds of Daubert hearings, and the submission of motions in limine, pre-trial memoranda, proposed trial exhibits, and proposed trial deposition testimony, the case settled for $150 million shortly before trial.

    This was a novel legal theory and may be the only successful effort to recover under this theory on antitrust liability.


“Fighting the high cost of healthcare,” Trial Magazine (October 2007)